Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Alembic Therapeutics LLC Announces Exclusive U.S. Distribution of NUVESSA® (metronidazole vaginal gel 1.3%)
-
FDA grants De Novo classification to Claria Medical for device designed to improve the safety and efficiency of hysterectomy procedures
-
Oriva Therapeutics announces the appointment of seasoned biotech entrepreneur Dr Agnès Arbat as Chief Executive Officer.
-
Hoag is now the first hospital in California to be designated a Center of Excellence in Multidisciplinary Endometriosis Care by the Surgical Review Corp
-
08. Juni 2026 09:00 ET | Quelle: Centre d’excellence sur la douleur chronique pour les vétérans canadiens
HAMILTON, Ontario, 08 juin 2026 (GLOBE NEWSWIRE) -- Un rapport national récemment publié appelle à une action urgente et coordonnée pour lutter contre la douleur chronique chez les femmes et les...
-
HAMILTON, Ontario, June 08, 2026 (GLOBE NEWSWIRE) -- A newly released national report is calling for urgent, coordinated action to address chronic pain among women and women Veterans, outlining a...
-
Clue is now first period and menstrual cycle tracker in the world to be covered by health insurance.
-
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- A new survey from Progyny (Nasdaq: PGNY), a global leader in women’s health and family building solutions, found that people navigating fertility,...
-
Progyny announces first-of-its-kind plan that expands access to comprehensive fertility benefits with predictable costs for small employers
-
Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure